GLAUKOS CORP (GKOS)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for GKOS
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| GKOS | Independent Director | 67 | ["Partner, InterWest Partners, a venture capital firm (1996 to 2015)","Managing Partner (2016 to current)","Investment Manager, Norwest Venture Partners (1995 to 1996)","Associate, TA Associates (1989 to 1992)","Board-certified ophthalmologist","Completed a retina research fellowship at Massachusetts Eye and Ear Infirmary","Residency training at Wills Eye Hospital"] | ["Compensation","Nominating and Governance"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| STAA | Director | 64 | ["Practicing ophthalmologist","Experience on the board of several U.S. public and private healthcare companies","Significant experience in financial markets","Managing Partner of InterWest Partners since 1996","Served on the board of directors of Glaukos Corporation since 2007","Director on the executive board of Orbis International","Former investment manager at Norwest Venture Partners","Former associate at TA Associates","Board-certified ophthalmologist","Completed retina research fellowship at Massachusetts Eye and Ear Infirmary","Residency training at Wills Eye Hospital","B.A. from Harvard University","M.D. from the University of Pennsylvania","M.B.A. from the Stanford Graduate School of Business"] | [] | 2023 |
Biography sourced from the proxy statement filing.
Age 67, Independent Director Since 2007 BOARD COMMITTEES Compensation, Nominating and Governance TERM EXPIRES: 2028 BACKGROUND Partner, InterWest Partners, a venture capital firm (1996 to 2015); Managing Partner (2016 to current) Investment Manager, Norwest Venture Partners (1995 to 1996) Associate, TA Associates (1989 to 1992) Dr. Kliman is a board-certified ophthalmologist and completed a retina research fellowship at Massachusetts Eye and Ear Infirmary and residency training at Wills Eye Hospital OTHER PUBLIC DIRECTORSHIPS Former STAAR Surgical Company (Nasdaq:STAA) (2020 to 2023) Doximity, Inc. (NYSE:DOCS) (2011 to 2022) Avedro, Inc. (Nasdaq:AVDR) (acquired by Glaukos Corporation) (2015 to 2019) Epocrates, Inc. (Nasdaq:EPOC) (1999 to 2011) IntraLase Corp. (Nasdaq:ILSE) (2000 to 2007) EDUCATION Bachelor of Arts, Harvard University M.D., University of Pennsylvania M.B.A., Stanford Graduate School of Business KEY EXPERTISE PROVIDED TO THE BOARD : Dr. Kliman s prior experience as a practicing ophthalmologist, as well as his significant experience in financial markets and prior experience on the boards of several U.S. public companies and various private healthcare companies, qualify him to serve on our Board of Directors. KEY SKILLS Capital Management Ophthalmology Mergers and Acquisitions Governance and Compliance Market Access Regulatory and Risk Management Other Public Company Board Service